KRITINUT Share Price Target 2035

CAGR-based price projection for Kriti Nutrients Limited (KRITINUT) targeting 2035, derived from official NSE exchange closing prices.

Bear Case (-1.0% CAGR)
Rs 61
2035 Target
Base Case (-2.5% CAGR)
Rs 53
2035 Target
Bull Case (-3.8% CAGR)
Rs 47
2035 Target

Current Market Snapshot

CMP: Rs 66.53
52W High: Rs 98.03
52W Low: Rs 66.53
1Y CAGR: -5.0%
3Y CAGR: -2.5%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 66 Rs 65 Rs 64
2028 Rs 65 Rs 63 Rs 62
2029 Rs 65 Rs 62 Rs 59
2030 Rs 64 Rs 60 Rs 57
2031 Rs 63 Rs 59 Rs 55
2032 Rs 63 Rs 57 Rs 53
2033 Rs 62 Rs 56 Rs 51
2034 Rs 61 Rs 54 Rs 49
2035 Rs 61 Rs 53 Rs 47

Other KRITINUT Price Targets

2025 2026 2027 2028 2030 2040 2050

Frequently Asked Questions

What is the KRITINUT share price target for 2035?

Based on historical growth analysis, the KRITINUT share price target for 2035 ranges from Rs 61 (conservative) to Rs 53 (base case) to Rs 47 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of KRITINUT?

The current market price of KRITINUT (Kriti Nutrients Limited) is Rs 66.53. The 52-week high is Rs 98.03 and 52-week low is Rs 66.53.

Is KRITINUT a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for KRITINUT price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at -1.0% CAGR), Base (-2.5% CAGR), and Bull (optimistic at -3.8% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.